What BMI do you need for Zepbound under Kentucky Medicaid?

For osa on Medicaid plans, Kentucky Medicaid requires a BMI of 30 or higher.

How long does a Zepbound approval last with Kentucky Medicaid?

Initial approvals last 6 months, and renewals are granted in 6-month periods.

What does Kentucky Medicaid require to renew Zepbound?

At least 5% weight loss from the starting weight and Renewal requires: (1) reduction in AHI/RDI/REI by >=15 events/hour OR >=50%; AND (2) at least 5% reduction in baseline body weight OR documentation assessing lifestyle and diet interventions if weight loss goal not met. Diabetes exclusion (history of diabetes or A1C >=6.5%) is re-verified at renewal. PAP trial requirement is NOT re-checked at renewal.

How current is this information?

This page reflects Kentucky Medicaid's written policy as of its current version, last verified against the source document on June 4, 2026.

Does Kentucky Medicaid cover Zepbound?

Zepbound for Osa

What Kentucky Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered with requirements

What you need to qualify

Age 18 and older
BMI of 30 or higher
Prescribed by or in consultation with a specialist
Diagnosed obstructive sleep apnea (AHI of 15 or higher), with a documented trial of PAP therapy
Not being used to treat type 1 diabetes

Qualification pathways

You can qualify through any one of these.

Initial Approval — Moderate-to-Severe OSA with Obesity

All of:

Diagnosis of moderate to severe obstructive sleep apnea (OSA)
BMI >= 30 kg/m2
Prescriber documentation of patient's baseline weight
Prescribed by or in consultation with a neurologist, sleep specialist, or other OSA specialist
Trial >= 3 months AND failure, contraindication, or intolerance of at least ONE PAP device (APAP, BiPAP, or CPAP)
Documentation that medication will be used with reduced calorie diet and increased physical activity
No history of diabetes
Current A1C < 6.5%
No personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
Requested dose does not exceed maximum FDA-approved dose
Not used in combination with another GLP-1 or dual GLP-1/GIP receptor agonist

Plus any one of:

AHI/RDI/REI >= 15 events/hour that is predominantly obstructive
AHI/RDI/REI >= 5 events/hour WITH at least ONE typical OSA symptom (unrefreshing sleep, daytime sleepiness, fatigue, insomnia, awakening with gasping/choking, loud snoring, or witnessed apneas)

Renewal — Continued OSA Treatment

All of:

Diagnosis of moderate to severe OSA and obesity
Prescribed by or in consultation with a neurologist, sleep specialist, or other OSA specialist
Documentation that medication will continue to be used with reduced calorie diet and increased physical activity
No history of diabetes
Current A1C < 6.5%
No personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
Requested dose does not exceed maximum FDA-approved dose
Not used in combination with another GLP-1 or dual GLP-1/GIP receptor agonist

Plus any one of:

Reduction in AHI/RDI/REI by >= 15 events/hour
Reduction in AHI/RDI/REI by >= 50%

Documentation to bring

Progress notes documenting confirmed diagnosis of moderate to severe OSA
AHI/RDI/REI value confirming >= 15 events/hour (predominantly obstructive) OR >= 5 events/hour with at least one typical OSA symptom
Documentation of BMI >= 30 kg/m2
Documentation of patient's baseline weight
Confirmation that prescriber is or has consulted with a neurologist, sleep specialist, or other OSA specialist
Documentation of >= 3-month trial with failure, contraindication, or intolerance of APAP, BiPAP, or CPAP
Prescriber attestation that medication will be used with reduced calorie diet and increased physical activity
Documentation confirming no history of diabetes
Current A1C result confirming < 6.5%
Confirmation of no personal or family history of MTC or MEN 2
For renewal: AHI/RDI/REI result showing >= 15 events/hour reduction or >= 50% reduction
For renewal: Documentation of >= 5% reduction in baseline body weight OR documentation assessing lifestyle and diet interventions if weight loss goal not met

Quantity limits

all strengths — 4 pens (2 mL) per 28 days

Approval and renewal

Initial approval: 6 months
Renewal: every 6 months
To renew, the plan looks for at least 5% weight loss from the starting weight and Renewal requires: (1) reduction in AHI/RDI/REI by >=15 events/hour OR >=50%; AND (2) at least 5% reduction in baseline body weight OR documentation assessing lifestyle and diet interventions if weight loss goal not met. Diabetes exclusion (history of diabetes or A1C >=6.5%) is re-verified at renewal. PAP trial requirement is NOT re-checked at renewal. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

History of diabetes (any type)
Current A1C >= 6.5%
Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Concomitant use of another GLP-1 or dual GLP-1/GIP receptor agonist

Policy note: This policy is for the OSA indication only. The document excludes patients with a history of diabetes OR current A1C >= 6.5%, making this a non-diabetic OSA population only. PAP device trial (APAP, BiPAP, or CPAP) for >= 3 months with failure, contraindication, or intolerance is required before approval. The AHI lower threshold pathway (AHI >= 5) requires at least one typical OSA symptom. At renewal, the AHI improvement threshold (>=15 events/hour OR >=50% reduction) must be documented. Weight loss of >= 5% from baseline is the renewal weight threshold, but if not met, documentation of lifestyle/diet interventions is an acceptable alternative. Managed by MedImpact Healthcare Systems on behalf of Kentucky Medicaid. Copyright 2025 MedImpact Healthcare Systems, Inc.

verified June 4, 2026 · source: zepbound_pa_criteria.pdf

Why Zepbound requests get denied by Kentucky Medicaid

Based on what this policy asks for. Fix these before the first submission.

Wrong brand for the diagnosis. Zepbound and Mounjaro are the same molecule with different approved uses; a request for Zepbound under a diagnosis that matches Mounjaro is routinely denied.
BMI not documented in the chart notes (or documented without a baseline weight and date).
Prescriber isn't the specialist the plan requires.
Baseline weight wasn't recorded at the start, so the required weight loss can't be shown at renewal.

Frequently asked questions

Does Kentucky Medicaid cover Zepbound?: Kentucky Medicaid covers Zepbound for osa with prior authorization on Medicaid.
What BMI do you need for Zepbound under Kentucky Medicaid?: For osa on Medicaid plans, Kentucky Medicaid requires a BMI of 30 or higher.
How long does a Zepbound approval last with Kentucky Medicaid?: Initial approvals last 6 months, and renewals are granted in 6-month periods.
What does Kentucky Medicaid require to renew Zepbound?: At least 5% weight loss from the starting weight and Renewal requires: (1) reduction in AHI/RDI/REI by >=15 events/hour OR >=50%; AND (2) at least 5% reduction in baseline body weight OR documentation assessing lifestyle and diet interventions if weight loss goal not met. Diabetes exclusion (history of diabetes or A1C >=6.5%) is re-verified at renewal. PAP trial requirement is NOT re-checked at renewal.
How current is this information?: This page reflects Kentucky Medicaid's written policy as of its current version, last verified against the source document on June 4, 2026.